Others
Showing 655 - 660 of 1213 results.
What Are the Legal Risks in Mass Torts & Insurance and Consumer Litigation?
3 Questions Decision-Makers Raise About Mass Torts, Insurance, and Consumer Litigation: Exposure windows and claim deadlines, settlement leverage and defense strategy, regulatory compliance and documentation standards.Mass torts, insurance, and consumer litigation present distinct exposure pathways for companies, insurers, and defendants who face aggregate claims from multiple plaintiffs. These cases demand early strategic positioning because the stakes compound rapidly. From a practitioner's perspective, the first 60 days after notice of a mass tort claim or consumer complaint often determine whether a defendant can shape the narrative, preserve evidence, and negotiate from strength. Decision-makers must understand how class certification thresholds, insurance coverage triggers, and regulatory reporting obligations interact to create liability exposure that extends far beyond a single lawsuit.
Read more
Regulatory Investigation Risk in Life Sciences: Act Early to Protect Your Business
3 Priority Considerations in Life Sciences Investigations and Enforcement Matters: Regulatory agency authority and scope of investigation, privilege and document protection during enforcement actions, settlement and compliance obligations.Life sciences investigations and enforcement actions represent a critical intersection of regulatory oversight, criminal liability, and civil remedies. These matters typically involve federal agencies (FDA, DOJ, FTC, HHS-OIG) and state regulators scrutinizing conduct in pharmaceutical development, clinical trials, medical devices, biologics, and healthcare billing. The stakes are substantial: civil penalties can reach tens of millions of dollars, criminal exposure extends to individuals and entities, and reputational damage often precedes financial loss. Counsel advising in-house compliance teams, corporate defendants, and executives must understand the mechanics of agency investigation, the scope of discovery obligations, and the strategic inflection points where early intervention shapes outcomes.
Read more
Life Sciences Risks Escalate without Early Regulatory and IP Strategy
3 Bottom-Line Points on Life Sciences from Counsel: Regulatory compliance varies by product type, jurisdiction, clinical trial protocols require pre-approvalLife sciences companies operate at the intersection of federal oversight, state licensing requirements, and international standards. Whether you are developing pharmaceuticals, medical devices, biologics, or diagnostics, the regulatory pathway shapes your timeline, budget, and competitive position. This article addresses the core legal and operational decisions that in-house counsel and business decision-makers must evaluate before moving forward.
Read more
3 Liability Risk Keys for Leisure Law Shared by a Lawyer
3 Bottom-Line Points on Leisure from Counsel: Liability exposure in leisure activities, contractual waivers, their enforceabilityLeisure businesses and individuals engaged in recreational activities face distinct legal exposures that often emerge only after an incident occurs. Whether you operate a leisure facility, organize group activities, or participate in recreational pursuits, understanding the legal framework that governs liability, risk management, and regulatory obligations is critical. This article addresses the core legal considerations that leisure operators and participants should evaluate before disputes arise.
Read more
Key Legal Considerations for Healthcare and Life Sciences Transactions
3 Priority Considerations in Healthcare and Life Sciences Transactions: Regulatory compliance across federal and state regimes, deal structure and tax implications, and reputational and antitrust exposure.Healthcare and life sciences transactions operate at the intersection of complex regulatory frameworks, fiduciary obligations, and market dynamics that few practitioners navigate routinely. Whether you are an in-house counsel evaluating an acquisition, a board member assessing a strategic partnership, or a transactional advisor structuring a financing, the stakes are substantial. A misstep in regulatory due diligence, a misalignment of representations and warranties, or a failure to anticipate enforcement risk can unwind months of negotiation and expose your organization to liability that extends well beyond the transaction itself.
Read more
Health Care Law: Regulations, Obligations and Rights Protection
3 Bottom-Line Points on Health Care from Counsel: Regulatory compliance obligations, patient privacy, data securityHealth care operations in the United States involve overlapping federal and state regulations that create significant compliance exposure. Whether you are an in-house counsel managing organizational risk, a provider navigating reimbursement disputes, or a decision-maker evaluating governance structures, understanding the legal framework that governs health care is essential to protecting your organization and ensuring ethical, lawful operations. This article addresses the core legal issues that most frequently create disputes, litigation exposure, or regulatory scrutiny in health care matters.
Read more